Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Anus Neoplasms 2Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Squamous Intraepithelial Lesions 1Sleep Apnea, Obstructive 1Sarcoma 1Rectal Neoplasms 1Precancerous Conditions 1Polycythemia Vera 1Pneumonia 1Pancreatic Neoplasms 1Pain 1Osteoporosis 1Oropharyngeal Neoplasms 1Obesity 1Mouth Neoplasms 1Lung Diseases, Interstitial 1Leukemia, B-Cell 1Hypertension 1Hypercholesterolemia 1Homosexuality 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1

Interventions

Cyproheptadine 2Watchful Waiting 1Standard of Care 1Observation 1Nutrition Therapy 1Megestrol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Body Weight Changes × Observation × Clear all
NCT01200602 2015-11-25

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

Mayo Clinic

Phase 2 Terminated
1 enrolled

Anorexia, Body Weight Changes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡